Delivery Order SPE2DR25D7005-SPE2DR26F3EXH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,516.25 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This firm fixed-price contract, awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $2,453.76 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,018.25 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,788,625 units of Moxifloxacin HCL 400 mg tablets and has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages) with a contract ceiling value of $1,188.24. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) at a firm fixed price ceiling value of $1,498.92. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,493,731 units of Moxifloxacin HCL 400 mg tablets. The contract has a potential value of $11,963.26 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of moxifloxacin HCL 400 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,265.17 and an ultimate completion date of September 15, 2025. The contract was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The Defense Logistics Agency (DLA) awarded a $3,530.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 tablets. The contract was competitively awarded without a set-aside designation and is scheduled for completion by January 29, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of 4,563,788,652 units of the pharmaceutical product Moxifloxacin Hydrochloride 400 mg Tablets to a location in Conshohocken, Pennsylvania. The potential value of this delivery order is $1,195.16, with a completion date of February 28, 2024....
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3EXHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,627.12 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packages of 50 units. This competitively awarded, firm fixed-price delivery order was issued on January 28, 2026, with an ultimate completion date of January 29, 2026. The pharmaceutical supplies will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate office. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. AmerisourceBergen's role as a primary pharmaceutical distributor to federal medical procurement enables efficient fulfillment of critical medical supply needs for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/27/26 |